State of health economic evaluation research in Saudi Arabia: A review

ClinicoEconomics and Outcomes Research

Volumn 4, Issue 1, 2012, Pages 177-184

  Al Aqeel, Sinaa A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Cost effective analysis; Economic evaluation; Pharmacoeconomics; Quality assessment; Saudi arabia

Indexed keywords

COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; EVALUATION RESEARCH; HEALTH CARE COST; HEALTH ECONOMICS; REVIEW; SAUDI ARABIA; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

EID: 84864302072     PISSN: None     EISSN: 11786981     Source Type: Journal    
DOI: 10.2147/ceor.s31087     Document Type: Review

References (32)

1. Ministry of Health. The Ministry of Health Statistics Book, 2009. Kingdom of Saudi Arabia. Available from: http://www.moh.gov.sa/en/Ministry/Statistics/book/Pages/default.aspx. Accessed May 3, 2012.
2. The Council of Cooperative Health Insurance. Available from: http://www.cchi.gov.sa/en/Pages/default.aspx. Accessed May 3, 2012.
3. Ministry of Finance. Ministry of Finance statement about the national budget for 2012. Kingdom of Saudi Arabia. Available from: http://www.mof.gov.sa/english/DownloadsCenter/Pages/Budget.aspx. Accessed May 3, 2012.
4. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. New York, NY: Oxford University Press; 2005.
5. Taylor R, Drummond MF, Salkeld G, Sullivan SD. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ. 2004;329:972-975.
6. Saudi Food and Drug Authority. Guidelines on pharmaceutical pricing. Available from: http://www.sfda.gov.sa/Ar/Drug/Topics/drug_reg/. Accessed May 3, 2012. Arabic.
7. Alsultan M. The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi Arabia. Saudi Pharmaceutical Journal. 2011;19:51-56.
8. Al-Tawfiq JA, Abed MS. Decreasing ventilator-associated pneumonia in adult intensive care units using the Institute for Healthcare Improvement bundle. Am J Infect Control. 2010;38:552-556.
9. Sabry A, Taha M, Nada M, Al Fawzan F, Alsaran K. Anticoagulation therapy during haemodialysis: a comparative study between two heparin regimens. Blood Coagul Fibrinolysis. 2009;20:57-62.
10. Ali M, White J, Lee CH, et al. Therapy conversion to biphasic insulin aspart 30 improves long-term outcomes and reduces the costs of type 2 diabetes in Saudi Arabia. J Med Econ. 2008;11:651-670.
11. Mammo L, Sheereen A, Saour T, Saour J. Comparative study between the light cycler and the PCR-restriction fragment length polymorphism in detecting factor V Leiden and factor II 20210G.A mutations. Clin Biochem. 2006;39:767-769.
12. Abbas M, Fiala L, Tawfiq L. Workplace influenza vaccination in two major industries in Saudi Arabia: a cost benefit analysis. J Egypt Public Health Assoc. 2006;81:59-73.
13. Pejaver RK, al Hifzi I, Aldussari S. Surfactant replacement therapy-economic impact. Indian J Pediatr. 2001;68:501-505.
14. Qari FA, Naser TA, Hashim IM, Tevaarwerk GJ. Outcome of thyrotoxicosis treatment with 3 different modalities. Saudi Med J. 2001;22:907-909.
15. Jawad AJ, Kurban K, el-Bakry A, al-Rabeeah A, Seraj M, Ammar A. Laparoscopic cholecystectomy for cholelithiasis during infancy and childhood: cost analysis and review of current indications. World J Surg. 1998;22:69-74.
16. Al Umran K, Yaseen H. Cost-effectiveness of surfactant replacement therapy in a developing country. J Trop Pediatr. 1997;43:167-169.
17. Kubeyinje EP. Cost-benefit of oral acyclovir in the treatment of herpes zoster. Int J Dermatol. 1997;36:457-459.
18. Alsultan MS, Mayet AY, Malhani AA, Alshaikh MK. Pattern of intravenous proton pump inhibitors use in ICU and Non-ICU setting: a prospective observational study. Saudi J Gastroenterol. 2010;16: 275-279.
19. Alangari AA, Abutaleb MH, Albarraq AA, Al-Dhowailie AA. Intravenous immunoglobulin utilization in a tertiary care teaching hospital in Saudi Arabia. Saudi Med J. 2008;29:975-979.
20. Jawadi AH, Abdul-Samad A. Intramedullary Kirschner wire (K-wire) fixation of femoral fracture in children. J Child Orthop. 2007;1:277-280.
21. Mitwalli AH, Abed J, Tarif N, et al. Dialyzer reuse impact on dialyzer efficiency, patient morbidity and mortality and cost effectiveness. Saudi J Kidney Dis Transpl. 2001;12:305-311.
22. Almuneef M, Dillon J, Abbas MF, Memish Z. Varicella zoster virus immunity in multinational health care workers of a Saudi Arabian hospital. Am J Infect Control. 2003;31:375-381.
23. Hoque ME, Khan JA, Hossain SS, et al. A systematic review of economic evaluations of health and health-related interventions in Bangladesh. Cost Eff Resour Alloc. 2011;9:12.
24. Gavaza P, Rascati KL, Oladapo AO, Khoza S. The state of health economic evaluation research in Nigeria, a systematic review. Pharmacoeconomics. 2010;28:539-553.
25. Gavaza P, Rascati K, Brown C, Lawson K, Mann T. The state of health economic and pharmacoeconomic evaluation research in Zimbabwe: a review. Pharmacoeconomics. 2008;69:268-285.
26. Teerawattananon Y, Russell S, Mugford M. A systematic review of economic evaluation literature in Thailand are the data good enough to be used by policy-makers? Pharmacoeconomics. 2007;25:467-479.
27. Lee SK, Brouwer WB, Lee S, Koo HW. Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? A critical review of published Korean economic evaluations. Pharmacoeconomics. 2005;23:709-721.
28. Neumann PJ, Stone PW, Chapman RH, Sandberg EA, Bell CM. The quality of reporting in published cost-utility analyses, 1976-1997. Ann Intern Med. 2000;132:964-972.
29. Jefferson T, Demicheli V, Vale L. Quality of systematic reviews of economic evaluations in health care. JAMA. 2002;287:2809-2812.
30. Jefferson T, Demicheli V. Quality of economic evaluations in healthcare: is it time for action to ensure higher methodological quality? BMJ. 2002;324:313-314.
31. Drummond MM, Sculpher M. Common methodological flaws in economic evaluations. Med Care. 2005;43:5-14.
32. Hjelmgren J, Berggren F, Andersson F. Health economic guidelines - similarities, differences and some implications. Value Health. 2001;4:225-250.